Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis. // Seminars in Hematology. – URL: https://www.sciencedirect.com/science/article/pii/S0037196326000612?dgcid=rss_sd_all
Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis. Seminars in Hematology. https://www.sciencedirect.com/science/article/pii/S0037196326000612?dgcid=rss_sd_all
“Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis.” Seminars in Hematology.
@article{article108646,
title = {Treatment of myeloproliferative neoplasms: Exploring new horizons of who and when to cytoreduce in patients with polycythemia vera and essential thrombocytosis},
journal = {Seminars in Hematology},
url = {https://www.sciencedirect.com/science/article/pii/S0037196326000612?dgcid=rss_sd_all}
}